Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125239371 | 12523937 | 1 | I | 20151224 | 20160704 | 20160704 | PER | US-JAZZ-2015-US-022514 | JAZZ | 0.00 | F | Y | 131.50000 | KG | 20160704 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125239371 | 12523937 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 125239371 | 12523937 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 125239371 | 12523937 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 125239371 | 12523937 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125239371 | 12523937 | 5 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125239371 | 12523937 | 6 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125239371 | 12523937 | 7 | C | ABILIFY | ARIPIPRAZOLE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125239371 | 12523937 | 8 | C | NUVIGIL | ARMODAFINIL | 1 | UNK | U | 0 | TABLET | |||||||||
| 125239371 | 12523937 | 9 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK | U | 0 | TABLET | |||||||||
| 125239371 | 12523937 | 10 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125239371 | 12523937 | 1 | Narcolepsy |
| 125239371 | 12523937 | 4 | Neuropathy peripheral |
| 125239371 | 12523937 | 5 | Narcolepsy |
| 125239371 | 12523937 | 7 | Product used for unknown indication |
| 125239371 | 12523937 | 8 | Product used for unknown indication |
| 125239371 | 12523937 | 9 | Product used for unknown indication |
| 125239371 | 12523937 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125239371 | 12523937 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125239371 | 12523937 | 1 | 201509 | 201510 | 0 | |
| 125239371 | 12523937 | 2 | 201510 | 201512 | 0 | |
| 125239371 | 12523937 | 3 | 201512 | 0 | ||
| 125239371 | 12523937 | 4 | 20151023 | 0 | ||
| 125239371 | 12523937 | 5 | 20150812 | 20150914 | 0 | |
| 125239371 | 12523937 | 6 | 20151023 | 0 | ||
| 125239371 | 12523937 | 7 | 20150915 | 20150926 | 0 | |
| 125239371 | 12523937 | 8 | 20150914 | 20151023 | 0 | |
| 125239371 | 12523937 | 9 | 20150812 | 20151023 | 0 | |
| 125239371 | 12523937 | 10 | 20150812 | 20150902 | 0 |